Cardiac Biomarkers Market Outlook, Consumption, Dynamics
and Shares Forecasts Till 2024
“Rising prevalence of cardiovascular diseases globally and escalating
popularity of POC testing are some of the main factors contributing toward
the market growth.”
Industry Insights
The Global Cardiac Biomarkers Market size was estimated at USD 4.7 billion in 2015. Rising prevalence of
cardiovascular diseases globally and escalating popularity of POC testing are some of the main factors
contributing toward the market growth.
Cardiac biomarkers are the substances released in the bloodstream due to heart related damage and stress. as
a result of insufficient blood supply to the heart. The detection of the biomarkers is used for the identification
of various heart conditions such as, acute coronary syndrome, acute myocardial infarction, ischemia, congestive
heart failure.
High prevalence of cardiovascular diseases worldwide has resulted into a significant growth in the cardiac
biomarkers market. According to the WHO, about 17.5 million people globally suffer from some heart condition.
The increasing preference to the use of the cardiac kits and more awareness among the people regarding the
application of the cardiac biomarkers is expected to augment the market in the near future.
Request Sample Copy of this Market Research @
https://www.millioninsights.com/industry-reports/cardiac-biomarker-market/request-sample